3/7
08:50 am
athe
Alterity Therapeutics Limited (NASDAQ: ATHE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $4.00 price target on the stock.
Low
Report
Alterity Therapeutics Limited (NASDAQ: ATHE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $4.00 price target on the stock.
3/7
08:50 am
athe
Alterity Therapeutics Limited (NASDAQ: ATHE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $4.00 price target on the stock.
Low
Report
Alterity Therapeutics Limited (NASDAQ: ATHE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $4.00 price target on the stock.
3/7
08:40 am
athe
Rating for ATHE
Low
Report
Rating for ATHE
3/7
08:40 am
athe
Rating for ATHE
Low
Report
Rating for ATHE